Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: OxfordVR’s Virtual Reality Program Treats Agoraphobia In Trial

Executive Summary

Results of a 346-patient randomized trial run by the UK’s National Health Service showed the automated virtual reality system developed by researchers at Oxford University helped people with agoraphobia re-engage with day-to-day activities outside their home.

You may also be interested in...



Novel VR Treatment For Mental Illness Gets FDA Breakthrough

The US FDA has granted its breakthrough designation to a virtual reality therapy that recreates everyday scenarios for patients dealing with severe anxiety and schizophrenia.

Minute Insight: CMR Surgical Teases Versius Virtual Reality Platform

The company has developed a headset allowing surgeons to remotely train on Versius.

HIMSS 2022: Penumbra Previews Expanded VR Rehabilitation System For Stroke With Planned Launch In April

Penumbra is expanding its virtual reality-based platform technology to assist stroke patients and other rehabilitation patients with its new Real System Y-Series with marketing plans for April.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel